The male index case III/15, who was diagnosed with multifocal, hormone receptor-positive, HER2-negative breast cancer at the age of 49 years, was tested by our laboratory in 2015 prior to our integration into the GC-HBOC. This evidence concerns the gene ERBB2 and breast cancer.